Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Patient Care | 943.3 | 831.6 | 905.7 | 857.4 | 852.0 | 563.8 | 875.0 | 837.1 |
| Products & Services | 398.0 | 359.2 | 395.9 | 383.5 | 367.6 | | 329.5 | 337.7 |
| Other | | | | | | 478.3 | | |
| Total revenues | 1,120.5 | 1,001.2 | 1,098.0 | 1,048.8 | 1,040.8 | 1,042.1 | 1,067.2 | 1,012.1 |
| Revenue growth [+] | 11.9% | -8.8% | 4.7% | 0.8% | -0.1% | -2.4% | 5.4% | 3.7% |
| Patient Care | 13.4% | -8.2% | 5.6% | 0.6% | 51.1% | -35.6% | 4.5% | 4.2% |
| Products & Services | 10.8% | -9.3% | 3.2% | 4.3% | | | -2.4% | -14.6% |
| Cost of goods sold [+] | 533.2 | 451.2 | 507.4 | 488.0 | 490.9 | 502.6 | 844.2 | 814.8 |
| Labor costs | 397.6 | 351.2 | 372.2 | 364.1 | 361.1 | 363.5 | 367.1 | 353.6 |
| Direct materials costs | | | | | | | 336.3 | 324.3 |
| Other direct costs | 135.6 | 100.0 | 135.2 | 123.9 | 129.8 | 139.0 | 140.8 | 136.9 |
| Gross profit | 587.3 | 549.9 | 590.6 | 560.8 | 549.8 | 539.5 | 223.0 | 197.3 |
| Gross margin | 52.4% | 54.9% | 53.8% | 53.5% | 52.8% | 51.8% | 20.9% | 19.5% |
| Selling, general and administrative [+] | 127.8 | 127.8 | 131.5 | 109.6 | 109.3 | 106.4 | 111.8 | 86.1 |
| General and administrative | 127.8 | 127.8 | 131.5 | 109.6 | 109.3 | 106.4 | 111.8 | 86.1 |
| Other operating expenses | 354.3 | 315.4 | 357.8 | 354.9 | 365.5 | 373.3 | 28.6 | 44.8 |
| EBITDA [+] | 105.2 | 106.8 | 101.4 | 96.3 | 75.0 | 59.8 | 82.5 | 66.4 |
| EBITDA growth | -1.5% | 5.3% | 5.3% | 28.3% | 25.6% | -27.6% | 24.3% | -55.0% |
| EBITDA margin | 9.4% | 10.7% | 9.2% | 9.2% | 7.2% | 5.7% | 7.7% | 6.6% |
| Depreciation | 27.6 | 28.8 | 30.9 | 29.8 | 29.8 | 31.0 | 32.5 | 31.5 |
| EBITA | 77.6 | 77.9 | 70.4 | 66.5 | 45.3 | 28.8 | 50.0 | 34.9 |
| EBITA margin | 6.9% | 7.8% | 6.4% | 6.3% | 4.4% | 2.8% | 4.7% | 3.4% |
| Amortization of intangibles | 4.9 | 6.0 | 5.0 | 6.7 | 9.5 | 13.9 | 13.8 | 7.4 |
| EBIT [+] | 72.7 | 71.9 | 65.4 | 59.8 | 35.8 | 14.9 | 36.2 | 27.5 |
| EBIT growth | 1.1% | 9.9% | 9.4% | 67.2% | 140.7% | -58.9% | 31.6% | -75.8% |
| EBIT margin | 6.5% | 7.2% | 6.0% | 5.7% | 3.4% | 1.4% | 3.4% | 2.7% |
| Non-recurring items [+] | | | | 0.2 | 54.7 | 86.2 | 385.8 | 0.2 |
| Asset impairment | | | | 0.2 | 54.7 | 86.2 | 385.8 | 0.2 |
| Interest expense | 28.9 | 32.4 | 34.3 | 37.6 | 57.7 | 45.2 | 29.9 | 28.3 |
| Interest expense | 28.9 | 32.4 | 34.3 | 37.6 | 57.7 | 45.2 | 29.9 | 28.3 |
| Other income (expense), net [+] | -0.7 | -0.6 | -0.7 | -17.7 | -0.7 | -6.8 | -7.2 | |
| Gain (loss) on debt retirement | | | | -17.0 | | -6.0 | -7.2 | |
| Pre-tax income | 43.1 | 38.8 | 30.5 | 4.4 | -77.4 | -123.3 | -386.7 | -1.0 |
| Income taxes | 1.2 | 0.6 | 3.0 | 5.2 | 27.3 | -15.9 | -67.6 | 2.0 |
| Tax rate | 2.7% | 1.6% | 9.7% | 119.6% | | 12.9% | 17.5% | |
| Net income | 42.0 | 38.2 | 27.5 | -0.9 | -104.7 | -106.5 | -327.1 | -19.0 |
| Net margin | 3.7% | 3.8% | 2.5% | -0.1% | -10.1% | -10.2% | -30.7% | -1.9% |
| |
| Basic EPS [+] | $1.09 | $1.01 | $0.74 | ($0.02) | ($2.89) | ($2.99) | ($8.96) | ($0.09) |
| Growth | 8.1% | 36.3% | -3264.8% | -99.2% | -3.5% | -66.6% | 10370.1% | -106.5% |
| Diluted EPS [+] | $1.07 | $0.99 | $0.72 | ($0.02) | ($2.89) | ($2.99) | ($8.96) | ($0.09) |
| Growth | 8.2% | 36.8% | -3198.5% | -99.2% | -3.5% | -66.6% | 10370.1% | -106.6% |
| |
| Shares outstanding (basic) [+] | 38.6 | 37.9 | 37.3 | 36.8 | 36.3 | 35.9 | 35.6 | 35.3 |
| Growth | 1.7% | 1.8% | 1.4% | 1.4% | 0.9% | 0.8% | 0.9% | 1.4% |
| Shares outstanding (diluted) [+] | 39.2 | 38.6 | 38.1 | 36.8 | 36.3 | 35.9 | 35.6 | 35.3 |
| Growth | 1.6% | 1.4% | 3.5% | 1.4% | 0.9% | 0.8% | 0.9% | 0.3% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|